Intended for healthcare professionals

Rapid response to:

Practice Therapeutics

Initial drug treatment in Parkinson’s disease

BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h4669 (Published 18 September 2015) Cite this as: BMJ 2015;351:h4669
Symptomatic treatment of Parkinson’s disease infographic
Click for an interactive graphic, showing more treatments for initial management of Parkinson’s disease.

Rapid Response:

Re: Initial drug treatment in Parkinson’s disease

I found this a helpful review. I wonder why entacapone (and its fixed drug combination Stalevo) was omitted. Many experts appear to be using Stalevo first line; I am not convinced of advantage and was disappointed that this is not addressed in this paper. Could the authors comment on this?

Competing interests: No competing interests

05 October 2015
Giles M Elrington
Neurologist
Oaks Hospital, Colchester